Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
People vary widely in their sensitivity to cold and heat -- but this could signal a thyroid problem.
Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Learn about the differences between these two HIV prevention options.
A study suggests cannabis use is linked to lower odds of neurocognitive problems in this population.
Study suggests immune-based cancer therapies might be particularly beneficial for HIV-positive people.
The latest revision recognizes the importance of treatment as prevention.
Around 38,000 new HIV cases still occur each year, and more than 80% of people who could benefit from PrEP aren’t using it.
Oncologist wins Senate backing by a vote of 72 to 18.
Abnormal anal screening results are common, but they often do not to lead to invasive cancer.
This malignancy, caused by human papillomavirus (HPV), can be prevented with a vaccine.
Rates of HIV acquisition were very low among people taking Descovy or Truvada, but Descovy had less effect on kidneys and bones.
HCV incidence in a Canadian study was lower than rates seen in some European countries.
The complaint alleges the company has profited from research spearheaded by the CDC.
A new study confirms that providing clean drug injection equipment slows the spread of HIV.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.